Using the Oncomine database (http://www.oncomine.org) [21], we also found that CHD1L expression was significantly increased in ovarian serous cystadenocarcinoma compared to normal ovarian tissue (P < 0.001) (Fig. 1A). Here, CHD1L is linked to ovarian serous cystadenocarcinoma.